CSIMarket
 


Exagen Inc   (XGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

Cumulative Exagen Inc 's Working Capital Ratio for Trailing Twelve Months Period

XGN's Working Capital Ratio for Trailing Twelve Months Period and Current Assets, Current Liabilities growth


Select the Comparisons : Select the Ratio:

XGN Working Capital Ratio for Trailing Twelve Months Period

(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Current Liabilities Growth 27.3 % -13 % -17.37 % -25.05 % -7.89 %
Y / Y Current Assets Growth -34.11 % -40.4 % -41.85 % -36.59 % -35.59 %
Working Capital Ratio for Trailing Twelve Months Period 6 7.17 7.85 8.53 8.9
Total Ranking # 306 # 509 # 500 # 514 # 554
Seq. Current Liabilities Growth 21.66 % 19.76 % -8.5 % -4.51 % -16.86 %
Seq. Current Assets Growth -2.18 % -4.61 % -21.98 % -9.5 % -11.51 %


Working Capital Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2023
On the trailing twelve months basis Due to growth in Current Liabilities in the IV. Quarter to $11 millions, average cumulative Working Capital Ratio for Trailing Twelve Months Period decreased to 6 below Exagen Inc average Working Capital Ratio for Trailing Twelve Months Period.
Working Capital Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Medical Laboratories industry 9 other companies have achieved higher Working Capital Ratio for Trailing Twelve Months Period than Exagen Inc . While overall ranking remained unchanged compare to previous quarter at no. .

What is Working Capital Ratio?
More about XGN
Working Capital Ratio XGN in the most recent quarter
Working Capital Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 10
Sector # 206
S&P 500 # 409


Working Capital Ratio for Trailing Twelve Months Period Statistics
High Average Low
14.45 10.05 5.36
(Dec 31 2021)   (Dec 31 2023)




Companies with similar average Working Capital Ratio for Trailing Twelve Months Period for 12 months ending Dec 31 2023, within Medical Laboratories Industry Working Capital Ratio for Trailing Twelve Months Period
Somalogic Inc   14.76 
Viridian Therapeutics Inc   14.54 
Maxcyte inc   14.01 
Check cap Ltd   12.51 
Omniab Inc   8.08 
Fulgent Genetics Inc   7.60 
Castle Biosciences Inc   7.58 
Dermtech Inc   7.30 
Bioaffinity Technologies Inc   7.24 
Exagen Inc   6.41 
Butterfly Network inc   6.35 
Absci Corp  6.21 
Guardant Health Inc   6.01 
Science 37 Holdings Inc   5.95 
Personalis Inc   5.32 
Veracyte inc   5.04 
Caredx Inc   4.75 
Natera inc   4.27 
Sera Prognostics Inc   4.03 
Hologic Inc  3.97 
Incyte Corporation  3.78 
Invitae Corporation  3.45 
Burning Rock Biotech Limited  3.38 
Nano x Imaging Ltd  3.29 
Bionexus Gene Lab Corp   3.25 
Vyant Bio Inc   3.14 
Ispecimen inc   3.02 
American Shared Hospital Services  2.86 
Luna Innovations Inc  2.81 
Exact Sciences Corporation  2.67 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com